Cantor Fitzgerald Reaffirms Overweight Rating for Johnson & Johnson (NYSE:JNJ)

Cantor Fitzgerald reiterated their overweight rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a report published on Tuesday, Benzinga reports. They currently have a $215.00 price objective on the stock. Several other research analysts have also weighed in on the company. Morgan Stanley upped their target price on Johnson & Johnson […]

Leave a Reply

Your email address will not be published.

Previous post Moody’s (NYSE:MCO) Price Target Raised to $514.00
Next post Loop Capital Cuts Lyft (NASDAQ:LYFT) Price Target to $16.00